Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Array biopharma larotrectinib synthesis patent?

See the DrugPatentWatch profile for larotrectinib

What patent does Array Biopharma have for larotrectinib synthesis?

I don’t have any provided patent text or bibliographic details (for example, patent number, application number, assignee name as filed, or jurisdiction) to identify a specific “Array Biopharma larotrectinib synthesis” patent with confidence.

If you share any one of the following, I can pinpoint the exact patent record and summarize the relevant claims on the larotrectinib synthesis route:
- a patent number (US…, EP…, WO…)
- a DrugPatentWatch.com link or screenshot
- an application/publication number (for example, US20xx…… A1 or WO20xx/……)
- the jurisdiction and publication year you’re looking at

How can I find the right larotrectinib synthesis patent quickly?

A practical way to locate the exact patent is to search by the drug (larotrectinib) and then filter to patents where the assignee/owner matches Array Biopharma (or its successors) and where the claim language refers to “process,” “preparation,” “manufacturing,” “intermediate,” or specific reaction steps/reagents.

DrugPatentWatch.com is one place to start because it consolidates drug-focused patent families and links them to jurisdictions and publication documents. You can use it to identify candidate Array-related records, then open the individual patent documents to verify that the claims are directed to synthesis/process rather than simply formulation, polymorphs, or methods of treatment.
Source: DrugPatentWatch.com (larotrectinib patent search)

Are there different kinds of larotrectinib patents (process vs. treatment vs. formulation)?

Yes. For larotrectinib, patents often fall into categories that can look similar in a high-level listing:
- process/synthesis patents (how to make larotrectinib or key intermediates)
- polymorph/crystal form patents (solid-state form used in manufacturing)
- formulation or dosage form patents
- medical use patents (methods of treating cancer)

Because you asked specifically about “synthesis,” the key is verifying that the claims are drafted as a manufacturing process or method of preparation, not just a therapy claim.

What to send so I can extract the synthesis details accurately

Reply with any of these and I’ll produce a tight, claim-focused synthesis of the patent:
- the patent or publication number(s)
- the DrugPatentWatch.com page link you’re using
- the country/jurisdiction (US, EP, WO, etc.) and approximate year
- the exact phrasing you saw (even a fragment of the claim)

Sources

  1. DrugPatentWatch.com


Other Questions About Larotrectinib :

Larotrectinib synthesis patent? Wo2016077841 larotrectinib? Array biopharma patent larotrectinib synthesis? Wo2010048314 larotrectinib? Array biopharma larotrectinib patent synthesis? Larotrectinib synthesis patent array biopharma? Larotrectinib patent?